Procurement teams negotiate aggressively on price. Quality Assurance reviews the Certificate of Analysis (COA) to verify assay and chemical purity.
Heer Pharma May Blog 1However, the COA often reveals little about how an Active Pharmaceutical Ingredient (API) will behave when it enters production.
The real challenge begins when the drum is opened.
Physical properties such as particle size distribution (PSD), bulk density, and powder flowability can significantly affect blending, compression, and dissolution. Even when an API meets all chemical specifications, variations in these characteristics can disrupt manufacturing and compromise product consistency.
Successful pharmaceutical sourcing requires evaluating not only what the material is chemically, but also how it performs under real production conditions.
The Reality of the Manufacturing Floor
Chemical purity ensures that a material passes incoming quality inspection. Physical consistency is what keeps production running smoothly.
Once an API enters dispensing and blending, its behavior becomes immediately apparent. If the density of the API differs substantially from that of the excipients, segregation may occur during transport to the tablet press. This separation can lead to content uniformity issues, batch deviations, and increased process variability.
In many cases, the COA remains fully compliant while production teams struggle with physical inconsistencies.
Particle Size Distribution and Dissolution Performance
Particle size distribution is one of the most critical factors affecting dissolution.
For poorly soluble APIs such as Albendazole and Mebendazole, micronization quality directly influences dissolution consistency and bioavailability. When PSD is too broad, fine particles may settle to the bottom of hoppers while coarser particles remain above.
This segregation creates variability that often becomes visible only during in-process testing or dissolution studies. Evaluating PSD during supplier qualification helps reduce the risk of costly formulation failures later in development or production.
Why Compression Problems Appear During Setup?
Tablet presses require powders with predictable and consistent flow properties. If an API exhibits poor flowability, die filling becomes uneven, causing tablet weight variation and reduced compression efficiency.
These challenges are frequently encountered with APIs such as Piroxicam and Lidocaine HCL. During setup, operators may observe:
Sticking and picking
Surface defects
Weight fluctuations
Lower production throughput
To maintain consistency, production speed is often reduced, increasing manufacturing costs.
Protecting API Integrity During Transportation
Physical properties can change significantly during transit.
Many APIs are hygroscopic and readily absorb moisture. This can transform free-flowing powders into compacted clumps that are difficult to dispense and blend accurately.
Shipment structure also matters. Fragmented Less than Container Load (LCL) shipments involve multiple handling steps and greater environmental exposure. Consolidated Full Container Load (FCL) transport helps minimize handling and supports the preservation of material consistency throughout the supply chain.
Documentation and Supplier Qualification(h3)
Reviewing chemical assay results is standard practice. Verifying physical property data requires a deeper technical assessment.
Sourcing teams should confirm that origin manufacturers:
Use validated laser diffraction methods for particle size analysis
Report PSD and density specifications clearly
Maintain complete Drug Master File (DMF) documentation
Operate under robust quality systems
Working with qualified suppliers and verified documentation helps ensure consistent API performance and reduces the risk of introducing unvetted materials into the supply chain.
Sourcing for Real Production Conditions
Manufacturing success depends on how materials behave on the production floor, not just on paper.
APIs with consistent physical properties improve blending, compression, dissolution, and overall process reliability.
Heer Pharma supports pharmaceutical sourcing through:
Documentation review
Verified material data
Supplier qualification support
Coordinated international shipment handling
For specific supply chain requirements or physical property reviews, connect with Heer Pharma.